Measuring the Human Variables Healthcare Systems Continue to Miss

Jul 30, 2026 | News

Image Source: AI generated, credited to OpenAI (ChatGPT)
Independent Contributor
Written by: Jasmine N. Dash, BCBA, LBA, M.Ed. Founder
On behalf of: Resonance Health

Healthcare organizations have never had more data available to them. Leaders monitor patient satisfaction scores, staffing ratios, productivity, quality indicators, denial rates, wait times, and length of stay. The dashboards are sophisticated, the reporting cadence is fast, and the appetite for measurement is real. Yet many organizations continue to face the same familiar challenges. Workforce burnout, turnover, inconsistent service delivery, communication breakdowns, and improvement initiatives that fade quietly after the launch meeting all persist across otherwise well-run systems.

The question is not whether healthcare organizations are measuring enough. The question is whether they are measuring early enough when issues are preventable.

The Cost of Waiting for the Outcome

Most healthcare metrics are lagging indicators. They describe conditions that have already settled. A clinician has already resigned. A patient has already left dissatisfied. Documentation has already fallen two weeks behind. By the time a number moves on a dashboard, the behavior that produced it has usually been occurring for months. By then, leaders are no longer preventing problems, they are responding to them.

That delay carries a price. A cost-consequence analysis published in Annals of Internal Medicine estimated that approximately 4.6 billion dollars in costs related to physician turnover and reduced clinical hours is attributable to burnout each year in the United States, or roughly 7,600 dollars per employed physician. Those costs accumulate during the long period when the underlying behavior is still visible and still changeable. They become countable only after the departure.

A similar delay appears in how quickly strong evidence reaches routine practice. A widely cited review in the Journal of the Royal Society of Medicine examined published estimates of translational time lags and concluded that the frequently repeated figure of seventeen years is harder to pin down than most people assume, while confirming that the interval between a finding and its everyday use is measured in years rather than months. Some of that interval is regulatory. Some is scientific. A meaningful portion is behavioral because evidence reaches practice only when people change what they do.

What the Behavior Was Already Telling You

Every organizational outcome is produced by thousands of small, observable actions. Each has discrete instances of things that occur before and after any given behavior. For example, supervisors either deliver feedback or they do not. Clinicians either escalate a concern, or they stay quiet. Teams either complete the handoff protocol as designed or they improvise around it. Schedulers either confirm the follow-up appointment before the patient leaves or they leave it to the portal.

These actions are observable, countable, and available long before the outcome arrives. That is what makes them meaningful.

Hand hygiene offers a clear illustration. The World Health Organization reports that average hand hygiene compliance without specific improvement interventions remains around 40 percent, rising to approximately 60 percent in critical care. Compliance is a behavior that occurs hundreds of times per work shift and can be counted in real time. Infection rate, by contrast, is an outcome that arrives weeks later. An organization tracking the behavior is working with a signal. An organization tracking only the infection rate is working with a receipt.

Behavior Is Shaped by the System Around It

Human factors research established this principle inside healthcare rather than importing it from outside. The Systems Engineering Initiative for Patient Safety model, published by Carayon and colleagues in 2006, placed the person at the center of the work system and argued that the interactions among tools, tasks, environment, and organizational conditions should be designed to support performance rather than to test individual resilience. Under that model, a workaround is information about the system, not a verdict on the worker themselves.

Organizational behavior management (OBM) contributes to the measurement discipline. A review of performance feedback in organizational settings covering studies published between 1985 and 1998 found that feedback does not uniformly improve performance, and that its effects become far more consistent when it is paired with clear antecedents (things that happen right before the behavior of interest), goal setting, and consequences. That finding matters in healthcare, where the standard response to a performance problem is to distribute more information. A dashboard functions as an antecedent typically. It rarely functions as a consequence.

The applied version is straightforward. In one electronic monitoring study on an orthopedic surgical ward, staff received weekly individualized reports comparing their own hand hygiene compliance with that of their colleagues. Compliance improved by roughly 15 percent overall and by 17 percent inside patient rooms. The clinical knowledge was already present before the study began. What changed was the arrangement of feedback and clarity around the behavior.

The Signal That Looks Like a Problem

The most instructive finding in this literature is one that arrived by accident. When Amy Edmondson set out to study the relationship between teamwork and medical error in hospitals, she expected stronger teams to make fewer mistakes. She found the opposite pattern. Better teams reported more errors, not fewer. The difference was not in how often mistakes happened but in whether people felt able to say so. That insight became the foundation of psychological safety research in medicine. Later work by Nembhard and Edmondson in neonatal intensive care units found that leader inclusiveness, meaning the visible availability and openness of leaders to input from staff, predicted team engagement in quality improvement efforts.

The measurement implication deserves attention. An organization watching only its error count might read a rising number as deteriorating quality when it may in fact indicate improving candor. The behavioral variable, whether people speak up and under what conditions, is what gives the outcome number its meaning. Without it, leaders are interpreting a number that can move in either direction for opposite reasons.

Behavior as a Leading Operational Indicator

Behavior is not a soft complement to operational data. It is the earliest operational indicator most healthcare organizations already have and rarely treat as one.

Perhaps the greatest opportunity for healthcare organizations is not collecting more data, but recognizing that behavior is data. Every interaction, decision, and routine provides measurable information about the health of the system producing it. Long before turnover appears in a quarterly report, behaviors begin to shift. Long before patient satisfaction declines, communication changes. Long before quality metrics deteriorate, small deviations emerge in how people coordinate, respond, and make decisions. Organizations willing to measure these early behavioral signals gain something increasingly valuable in healthcare: the opportunity to intervene while improvement is still possible rather than after performance has already declined. Every figure on an executive dashboard is a record of behavior that has already occurred. In each case the outcome is the summary, though the behavior is the source.

The same logic explains why improvement initiatives so often fade. Implementation science has spent two decades demonstrating that programs frequently fail not because the model was wrong, but because delivery drifted after the training ended and nobody was measuring delivery. Fidelity is a behavioral measure and organizations that track it can intervene while the initiative is still alive. Organizations that track only the end-of-year result learn about the drift once the funding cycle has closed.

Building Systems That Support Human Performance

Healthcare professionals enter these fields because they want to make a meaningful difference. Most organizations are staffed by capable, committed people working inside increasingly complex environments. When performance declines, it is tempting to conclude that people need more accountability, more training, more motivation, or simply, they’re not the right people for the role.

The research however supports that sustainable performance depends on designing conditions that make the desired behavior easy, visible, and reinforced. Clear expectations, feedback that is timely and specific, psychological safety strong enough that concerns surface early, workflows that reduce friction on the correct action, and recognition tied to behavior rather than to outcome alone all influence daily performance in ways that can be measured.

These conditions are within the reach of a unit director as readily as a chief executive. The variables that matter most are not fixed traits of the workforce. They are features of the environment, and features of an environment can be changed.

Measuring What Matters Most

Healthcare has made remarkable advances in measuring clinical outcomes, financial performance, and operational efficiency. The next advance is measuring the human behaviors that generate those outcomes in the first place. Every organizational outcome reflects the cumulative effects of behavior interacting with the systems in which it occurs. Executive dashboards summarize what has already happened. Behavior reveals what is happening now. When leaders learn to recognize those behavioral patterns early, they gain the opportunity to improve performance before today’s behaviors become tomorrow’s outcomes.

Behavior is not simply another variable inside a healthcare system. It is the mechanism through which every healthcare system or business operates. Organizations that learn to measure and support these human variables tend to find that their most persistent operational challenges become not only more understandable but considerably more solvable.

Behavior is measurable. Human performance becomes more understandable when behavior is measured well. Better understanding creates better decisions, and better decisions improve outcomes. Change is possible. Results follow.

 

Author Bio

    Jasmine Dash, BCBA, LBA, M.Ed. is the Founder and CEO of Resonance Health, where she studies and applies the science of human performance across individuals, teams, and healthcare organizations. Using behavioral science as the foundation, her work focuses on making human performance measurable by identifying the behavioral and environmental conditions that influence decision making, implementation, resilience, leadership, and sustainable change. She partners with healthcare organizations to improve operational performance while also working with individuals to strengthen personal effectiveness, alignment, and long term growth. Jasmine is actively engaged in research exploring how observable behavior can serve as an early indicator of performance across both individuals and complex systems. Her work aims to bridge behavioral science, organizational performance, and human potential through practical, measurable applications. Connect with her on LinkedIn.
    References:

    Han, S., Shanafelt, T. D., Sinsky, C. A., Awad, K. M., Dyrbye, L. N., Fiscus, L. C., Trockel, M., and Goh, J. (2019). Estimating the attributable cost of physician burnout in the United States. Annals of Internal Medicine, 170(11), 784 to 790. https://doi.org/10.7326/M18-1422

    Morris, Z. S., Wooding, S., and Grant, J. (2011). The answer is 17 years, what is the question. Understanding time lags in translational research. Journal of the Royal Society of Medicine, 104(12), 510 to 520. https://doi.org/10.1258/jrsm.2011.110180

    World Health Organization. (2023, May 12). First ever WHO research agenda on hand hygiene in health care to improve quality and safety of care. https://www.who.int/news/item/12-05-2023-first-ever-who-research-agenda-on-hand-hygiene-in-health-care-to-improve-quality-and-safety-of-care

    Carayon, P., Schoofs Hundt, A., Karsh, B. T., Gurses, A. P., Alvarado, C. J., Smith, M., and Flatley Brennan, P. (2006). Work system design for patient safety. The SEIPS model. Quality and Safety in Health Care, 15(Suppl 1), i50 to i58. https://doi.org/10.1136/qshc.2005.015842

    Alvero, A. M., Bucklin, B. R., and Austin, J. (2001). An objective review of the effectiveness and essential characteristics of performance feedback in organizational settings (1985 to 1998). Journal of Organizational Behavior Management, 21(1), 3 to 29. https://doi.org/10.1300/J075v21n01_02

    From-Hansen, M., Hansen, M. B., Hansen, R., Sinnerup, K. M., and Emme, C. (2024). Empowering health care workers with personalized data driven feedback to boost hand hygiene compliance. American Journal of Infection Control, 52(1), 21 to 28. https://www.ajicjournal.org/article/S0196-6553(23)00655-7/fulltext

    Edmondson, A. C. (1996). Learning from mistakes is easier said than done. Group and organizational influences on the detection and correction of human error. The Journal of Applied Behavioral Science, 32(1), 5 to 28.

    Association of American Medical Colleges. (2019, November 13). Amy Edmondson. Psychological safety is critically important in medicine. https://www.aamc.org/news/amy-edmondson-psychological-safety-critically-important-medicine

    Nembhard, I. M., and Edmondson, A. C. (2006). Making it safe. The effects of leader inclusiveness and professional status on psychological safety and improvement efforts in health care teams. Journal of Organizational Behavior, 27(7), 941 to 966. https://doi.org/10.1002/job.413

    All content is published for informational purposes only and does not constitute medical, legal, or investment advice. For more information, see our Terms and Conditions

    Articles that may be of interest

    Weekly News Roundup | 27 July 2026

    Weekly News Roundup | 27 July 2026

    Life science news 27 July 2026: GSK wins its first lung cancer approval with a selective ROS1 inhibitor, Lilly's triple agonist retatrutide delivers up to 22.6 per cent weight loss in two pivotal trials, and the MHRA clears what it calls the world's first lower-carbon...

    read more
    Weekly News Roundup | 20 July 2026

    Weekly News Roundup | 20 July 2026

    Life science news 20 July 2026: the FDA approves the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly makes the largest psychedelics deal in Big Pharma history, and a first-in-class breast cancer therapy wins regulatory clearance in a landmark week for...

    read more
    Biopharma H1 2026 Review: Deals, Drugs, and Pipeline Shifts

    Biopharma H1 2026 Review: Deals, Drugs, and Pipeline Shifts

    The first half of 2026 delivered one of the most consequential periods in recent biopharma history, reshaping competitive landscapes through record dealmaking, landmark regulatory approvals, and pivotal clinical breakthroughs. This biopharma H1 2026 review examines...

    read more
    How Climate Change is Redrawing Europe’s Disease Landscape

    How Climate Change is Redrawing Europe’s Disease Landscape

    The impact of climate change is usually discussed in terms of heatwaves and floods. While less visible, its impact on infectious diseases is equally consequential for public health.  New data from the UK Health Security Agency (UKHSA) showing a surge in chikungunya...

    read more

    Articles that may be of interest

    Weekly News Roundup | 27 July 2026

    Weekly News Roundup | 27 July 2026

    Life science news 27 July 2026: GSK wins its first lung cancer approval with a selective ROS1 inhibitor, Lilly's triple agonist retatrutide delivers up to 22.6 per cent weight loss in two pivotal trials, and the MHRA clears what it calls the world's first lower-carbon...

    read more
    Weekly News Roundup | 20 July 2026

    Weekly News Roundup | 20 July 2026

    Life science news 20 July 2026: the FDA approves the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly makes the largest psychedelics deal in Big Pharma history, and a first-in-class breast cancer therapy wins regulatory clearance in a landmark week for...

    read more
    Biopharma H1 2026 Review: Deals, Drugs, and Pipeline Shifts

    Biopharma H1 2026 Review: Deals, Drugs, and Pipeline Shifts

    The first half of 2026 delivered one of the most consequential periods in recent biopharma history, reshaping competitive landscapes through record dealmaking, landmark regulatory approvals, and pivotal clinical breakthroughs. This biopharma H1 2026 review examines...

    read more
    How Climate Change is Redrawing Europe’s Disease Landscape

    How Climate Change is Redrawing Europe’s Disease Landscape

    The impact of climate change is usually discussed in terms of heatwaves and floods. While less visible, its impact on infectious diseases is equally consequential for public health.  New data from the UK Health Security Agency (UKHSA) showing a surge in chikungunya...

    read more